UNSPSC 41202039: Mycobacterium tuberculosisimmunofluorescent reagents

In this classification, Mycobacterium tuberculosis immunofluorescent reagents are devices used in test to identify specific Mycobacterium tuberculosis immunofluorescent reagents antibodies in serum. US FDA regulates Mycobacterium tuberculosis immunofluorescent reagents under 21 CFR 866.3370 and under FDA product code GRT.

UNSPSC 41202039 Mycobacterium tuberculosis immunofluorescent reagents is a Commodity code that in practice encompasses HIV, Syphilis, and Hepatitis testing reagents and related diagnostic laboratory supplies procured by state and local public health departments, correctional agencies, and municipalities. The recent solicitation activity shows substantial mismatch between the code's nominal scope (tuberculosis-specific immunofluorescent reagents) and what state and local governments actually purchase under this classification — the opportunities posted are almost entirely for HIV screening assays, Syphilis reagents, clinical diagnostic blood chemistry services, and forensic laboratory analysis. State and local issuing bodies include state departments of public health (Illinois, Texas), county correctional supervision departments (Collin County, Texas), municipal health programs (City of Austin), and university health centers (University of Houston). The work solicited ranges from consumable reagent supply contracts for automated screening platforms to comprehensive specimen collection and testing services with staffing and laboratory certification requirements, along with expert witness testimony for forensic analysis.

Illinois Department of Public Health leads recent activity with multiple procurements: an IFB for five-year HIV/Syphilis/Hepatitis 4th generation screening assays and instrumentation (due March 16, 2026), and emergency procurements for Abbott reagent kits (February–August 2026). Collin County Community Supervision and Corrections Department issued an RFP for offender specimen collection and drug testing services covering two collection sites in Plano and McKinney with approximately 25,031 annual tests and an estimated contract value of $600,000 (due July 23, 2026). The City of Austin posted an IFB for rapid HIV test kits at 375 units annually (due July 17, 2026). Texas Department of Criminal Justice solicited forensic analysis services including urine and feces stain identification with expert witness testimony (due May 13, 2026). University of Houston sought clinical diagnostic blood chemistry reagents and testing services for its Student Health Center (due March 24, 2026). Activity concentrates in Texas (Collin County, Austin, TDCJ) and Illinois (IDPH multiple contracts), with recent opportunities spanning February through July 2026.